Additional Details
-
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Summit HealthBend OR. 97701 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
NYU Langone HealthNew York NY. 10017 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
AccellacareWilmington NC. 28401 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Paradigm Clinical Research - ReddingRedding CA. 96001 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Clinical Site PartnersWinter Park FL. 32789 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Renstar Medical ResearchOcala FL. 34470 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Southeastern Research CenterWinston-Salem NC. 27103 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Lowcountry Lung and Critical CareCharleston SC. 29406 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Newport Native MD, Inc.Newport Beach CA. 92663 -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis
Clinical Site Partners, LCCLeesburg FL. 34748 -
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
NIEHS Clinical Research Unit (CRU)Research Triangle Park NC. 27709 -
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
University of VirginiaCharlottesville VA. 22908 -
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF
Southeastern Research CenterWinston Salem NC. 27103 -
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF
MUSC Pulmonary ResearchCharleston SC. 29425 -
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF
Montefiore Medical CenterBronx NY. 10467 -
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF
Mayo ClinicJacksonville FL. 32224 -
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF
Newport Native MD, Inc.Newport Beach CA. 92663 -
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
GSK Investigational SiteSaint Petersburg FL. 33704 -
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
GSK Investigational SiteVancouver V5Z 1M9 -
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
GSK Investigational SiteHamilton L8N 4A6